Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum secretory and trafficking pathway is a specialized system used by the malaria parasite to transport proteins from its cytoplasm to various internal organelles and into the host erythrocyte. This pathway includes the endoplasmic reticulum (ER), Golgi apparatus, and unique structures such as the apicoplast and the Plasmodium Translocon of Exported Proteins (PTEX) located at the parasitophorous vacuole membrane (PVM) (Deponte, 2012, PMID: 22531113; Elsworth et al., 2014, PMID: 25043010). It is vital for the parasite's ability to remodel the host cell, acquire nutrients, and evade the host immune system by exporting virulence factors like PfEMP1 (Cooke et al., 2004, PMID: 15145198). Key enzymes within this pathway, such as Plasmepsin V, which cleaves the Plasmodium Export Element (PEXEL) motif, are essential for the maturation of exported proteins (Boddey et al., 2010, PMID: 20130577). Drugs targeting this pathway, such as Brefeldin A or experimental Plasmepsin V inhibitors like WEHI-916, disrupt these critical transport processes, leading to parasite death (Sleebs et al., 2014, PMID: 24991914). Given the divergence of some pathway components from human orthologs, it serves as a significant area for the development of novel antimalarials (Heiber et al., 2013, PMID: 23418187).
Inhibition of protein translocation into the endoplasmic reticulum, blockade of PEXEL motif cleavage by Plasmepsin V, disruption of Golgi-mediated vesicle trafficking, or inhibition of the PTEX translocon at the parasitophorous vacuole membrane.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum secretory and trafficking pathway.